Stem-cell funding still mired in courts
By Steve Johnson,
San Jose Mercury News
| 11. 30. 2005
JUDGE RULES SUITS ON PROPOSITION 71 CAN GO TO TRIAL
By Steve Johnson
Mercury News
A judge Tuesday denied a motion to dismiss two lawsuits challenging the legality of California's year-old $3 billion stem-cell institute, making it likely public funding for the institute will continue to be blocked well into next year.
Alameda County Superior Court Judge Bonnie Sabraw also denied motions by the plaintiffs, who had asked her to declare the stem-cell program unconstitutional.
Sabraw ordered the parties back to court Tuesday to set a trial date, noting that she planned to ``proceed to trial promptly.'' Both sides in the case said it's possible a trial might not begin until spring. Whoever loses at that point is expected to file an appeal, dragging the case out even longer.
Even so, Robert Klein, who chairs the California Institute for Regenerative Medicine, said he was happy with the judge's ruling because it found no immediate reason to declare the stem-cell program unconstitutional.
``We would have loved to have a home run,'' by having the suits dismissed, Klein said. ``But boy, this...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...
